01951.HK
Jinxin Fertility Group Limited
HKSE · Healthcare · Medical - Care Facilities · CN
HKD 2.20
+3.05%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 5.3B | 2.6B | 2.8B | 2.8B | 2.4B |
| Cost of Revenue | 3.5B | 1.8B | 1.7B | 1.6B | 1.5B |
| Gross Profit | 1.9B | 818.4M | 1.1B | 1.2B | 913.1M |
| Operating Expenses | |||||
| R&D Expense | 45.9M | 20.1M | 24.7M | 21.7M | 17.5M |
| SG&A Expense | 1.3B | 662.7M | 633.2M | 673.2M | 610.3M |
| General & Admin Expense | 461.3M | 497.7M | 458.0M | 481.4M | 458.9M |
| Selling & Marketing Expense | 162.7M | 165.0M | 175.2M | 191.9M | 151.4M |
| Other Expenses | — | (62.3M) | — | — | — |
| Total Operating Expenses | 1.4B | 620.5M | 657.9M | 695.0M | 627.8M |
| Cost and Expenses | 4.9B | 2.4B | 2.4B | 2.3B | 2.1B |
| Operating Income (EBIT) | 467.3M | 197.9M | 441.6M | 480.5M | 285.4M |
| Non-Operating | |||||
| Interest Income | 14.3M | 9.2M | 7.5M | 20.7M | 28.3M |
| Interest Expense | 149.3M | 69.2M | 57.4M | 79.6M | 71.9M |
| Net Interest Income | (142.4M) | (60.1M) | (49.9M) | (58.9M) | (43.5M) |
| Other Non-Op Income/Expense | (1.2B) | (1.2B) | (49.7M) | (16.2M) | (131.0M) |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | (705.5M) | (957.5M) | 391.9M | 464.3M | 154.3M |
| Income Tax Expense | 176.2M | 900.1K | 118.4M | 117.3M | 36.4M |
| Bottom Line | |||||
| Net Income | (777.9M) | (950.9M) | 283.1M | 344.7M | 121.1M |
| Earnings from Cont. Ops | (881.7M) | (958.4M) | 273.5M | 347.0M | 117.9M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (777.9M) | (950.9M) | 283.1M | 344.7M | 121.1M |
| Per Share | |||||
| Basic EPS | (HK$0.29) | (HK$0.35) | HK$0.10 | HK$0.13 | HK$0.05 |
| Diluted EPS | (HK$0.29) | (HK$0.35) | HK$0.10 | HK$0.13 | HK$0.05 |
| Revenue Per Share | HK$2.04 | HK$0.94 | HK$1.03 | HK$1.02 | HK$0.95 |
| Shares | |||||
| Basic Shares Outstanding | 2.6B | 2.7B | 2.7B | 2.7B | 2.5B |
| Diluted Shares Outstanding | 2.7B | 2.7B | 2.7B | 2.7B | 2.6B |
| Profitability Metrics | |||||
| EBITDA | 1.0B | 538.6M | 645.1M | 682.0M | 476.2M |
| D&A | 575.3M | 340.7M | 203.5M | 201.5M | 190.8M |
| EBIT | 467.3M | 197.9M | 441.6M | 480.5M | 285.4M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026